66
Participants
Start Date
October 23, 2023
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2024
CS6253 Solution for Injection
Solution for intra-venous injection, 50mg CS6253 /mL. Single-use vials containing 100 mg CS6253 (2 mL of 50 mg/mL concentration)
Placebo
Physiological saline solution for intra-venous injection
La Paz University Hospital, Madrid
Lead Sponsor
National Institute on Aging (NIA)
NIH
Artery Therapeutics, Inc.
INDUSTRY